Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biomerieux SA Announces Acquisition Of BioFire Diagnostics Inc.


Tuesday, 3 Sep 2013 12:20pm EDT 

Biomerieux SA announced that it has entered into an agreement to acquire BioFire Diagnostics Inc., a privately held U.S.-based company specialized in molecular biology. Under the terms of the agreement, bioMérieux will acquire 100% ownership of BioFire. The transaction will include a $450 million acquisition price and the company`s net financial debt. Completion of this acquisition remains subject to usual closing conditions, in particular certain regulatory approvals. The deal is expected to close by the end of the fiscal year or in early 2014 and consequently will not have much impact on sales and current operating income before non-recurring items in 2013. Acquisition costs will amount to EUR6 million to be recorded under non-recurring items. This acquisition will be funded through indebtedness. 

Company Quote

81.91
0.21 +0.26%
15 Sep 2014